4.9
30000+ People
Trusting us!
FAQ
General Questions
Find answers to our most frequently asked questions about Unicorn-Biotech Holding GmbH, our services, and how we support laboratory innovation across Europe. Can't find what you need? Contact us directly.
Unicorn-Biotech Holding GmbH is an Austrian biotechnology holding company headquartered in Vienna (Czerninplatz 4, 1020 Vienna). We specialise in advanced genomic sequencing, cell-line and assay development, bio-pharmaceutical quality control, and molecular & chemical diagnostics. Our services help research labs, universities, and pharmaceutical companies comply with international standards and accelerate scientific breakthroughs.
We serve a broad range of scientific sectors across Europe, including clinical diagnostics companies, pharmaceutical firms, agricultural research agencies, industrial biochemical manufacturers, private molecular labs, and university life science departments. Any team conducting biological, genetic, or molecular research can benefit from our high-throughput testing and development support.
Our office is located at Czerninplatz 4, 1020 Vienna, Austria. We operate primarily across Austria, with particular strength in Vienna and the surrounding federal states. For large-scale infrastructure projects we also engage with partners across Central and Eastern Europe. Contact us at help@unicornbiotech.at to discuss on-site visit availability in your region.
Simply use our Contact page to send us a message, describe your biological targets or testing requirements, and one of our laboratory experts will get back to you within one business day. You can also reach us directly at help@unicornbiotech.at.
Research
Genomics & Laboratory Assays
Common questions about our gene sequencing procedures, biological sample submission guidelines, turnaround times, and molecular assay capabilities.
We offer a wide range of genomic solutions, including high-throughput next-generation sequencing (NGS) for whole genomes, targeted gene panels, metagenomics, and RNA sequencing. Additionally, we provide custom gene synthesis, plasmid design, and CRISPR-Cas9 editing diagnostics to verify sequence accuracy. All genomic projects are tailored to your research or clinical goals.
Clients can submit biological samples directly to our Vienna facility following our specific collection guidelines (e.g. frozen on dry ice or in RNA preservation buffer). Once registered, samples are stored at -80°C to preserve integrity. Standard genomic sequencing results are delivered via a secure data portal within 2–4 business days. Custom molecular assay validation typically takes 5–10 business days.
Yes. Following every laboratory assay, we issue officially signed analysis certificates detailing gene alignment metrics, sequence purity, variant call formats (VCFs), and applicable biological indices. These reports are formatted to comply with GLP/GMP standards and are ready for submission to regulatory bodies or inclusion in peer-reviewed scientific publications.
Absolutely. We specialize in bioreactor expression optimization, cell-line growth characterization, and high-yield protein purification. Our team works with pharmaceutical partners to automate liquid handling protocols, scale up mammalian or microbial culture batches, and integrate robotic screening to minimize manual errors and accelerate assay timelines.
Quality
Diagnostics & Quality Control
Frequently asked questions about our biomarker screening, assay validation, biopharmaceutical QC clearance, and certified laboratory standards.
We offer highly sensitive biomarker panels using multiplex ELISA, bead-based flow cytometry, and qPCR. Our standard panels focus on oncology targets, immunological responses, metabolic markers, and customized research assays. Our molecular profiling identifies specific cell line traits and gene expression changes to support early-stage therapeutic discovery.
Unicorn-Biotech Holding GmbH operates state-of-the-art facilities compliant with Good Laboratory Practice (GLP) and ISO 9001 standards. Our diagnostic and analytical labs are accredited to ISO/IEC 17025, ensuring that all calibration, pipette automation, and sample tracking protocols satisfy international scientific audits and quality assessments.
Yes. We support drug release pipelines with endotoxin testing, mycoplasma detection, protein purity validation via HPLC and capillary electrophoresis, and active pharmaceutical ingredient (API) stability testing. Our stability chambers can simulate various environmental conditions in compliance with ICH guidelines for clinical trial batch clearance.
Yes. Our assay development engineers work closely with clinical and industrial partners to design custom biological assays. We handle initial target validation, primer design, cell culture transfection, signal-to-noise ratio optimization, and final assay validation to ensure a robust test ready for scaling or commercial applications.